Working… Menu

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma (ALDI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00383097
Recruitment Status : Terminated (The trial was terminated in 2010 due to lack of enrollment.)
First Posted : October 2, 2006
Last Update Posted : May 24, 2012
Texas Children's Hospital
The Methodist Hospital System
Information provided by (Responsible Party):
Stephen Gottschalk, Baylor College of Medicine

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 2010
Actual Study Completion Date : February 2010